Role of poly(ADP-ribose) glycohydrolase (PARG) in shock, ischemia and reperfusion

Pharmacological Research

Volumn 52, Issue 1 SPEC. ISS., 2005, Pages 100-108

  Cuzzocrea, Salvatore ^a   Wang, Zhao Qi ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Inflammation; Ischemia; PARG; PARP 1; Shock; Tissue damage

Indexed keywords

1,2,3,4,6 O INHIBIPENTA BETA DEXTRO GALLOYLGLUCOSE; 1,2,3,4,6 O PENTA BETA DEXTRO GALLOYLGLUCOSE; ADENOSINE DIPHOSPHATE (HYDROXYMETHYL)PYRROLIDINEDIOL; CATECHOLAMINE; DAUNORUBICIN; DOPAMINE; ELLIPTICINE; ETHACRIDINE; GPI 16552; GPI 18214; N BIS(3 PHENYLPROPYL) 9 OXOFLUORENE 2,7 DIAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NORADRENALIN; POLY ADP RIBOSE GLYCOHYDROLASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROFLAVINE; PYRROLIDINE DERIVATIVE; TANNIN; TANNIN DERIVATIVE; TILORONE DERIVATIVE; UNCLASSIFIED DRUG;

BRAIN ISCHEMIA; BURN; CELL ISOLATION; DROSOPHILA; GENE INACTIVATION; GENETIC ENGINEERING; GENOTOXICITY; HOMEOSTASIS; ISCHEMIA; KIDNEY ISCHEMIA; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; NONHUMAN; PANCREATITIS; PATHOGENESIS; PERITONITIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RODENT; SEPTIC SHOCK; SHOCK; TISSUE INJURY;

EID: 19444366619     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.02.009     Document Type: Article

References (103)

1. + depletion and cell death induced by oxidative stress J Biol Chem 278 2003 18426 18433
2. C. Szabò, L.H. Lim, S. Cuzzocrea, S.J. Getting, B. Zingarelli, and R.J. Flower Inhibition of poly(ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects J Exp Med 186 1997 1041 1049
3. S. Cuzzocrea, B. Zingarelli, G. Costantino, A. Sottile, D. Teti, and A.P. Caputi Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat Crit Care Med 27 1999 1517 1523
4. J.T. Slama, N. Aboul-Ela, D.M. Goli, B.V. Cheesman, A.M. Simmons, and M.K. Jacobson Specific inhibition of poly(ADP-ribose) glycohydrolase by adenosine diphosphate (hydroxymethyl)pyrrolidinediol J Med Chem 38 1995 389 393
5. W. Lin, J.C. Ame, N. Aboul-Ela, E.L. Jacobson, and M.K. Jacobson Isolation and characterization of the cDNA encoding bovine poly(ADP-ribose) glycohydrolase J Biol Chem 272 1997 11895 11901
6. E. Winstall, E.B. Affar, R. Shah, S. Bourassa, I.A. Scovassi, and G.G. Poirier Preferential perinuclear localization of poly(ADP-ribose) glycohydrolase Exp Cell Res 251 1999 372 378
7. Genome sequence of the nematode C. elegans: a platform for investigating biology. The C. elegans sequencing consortium. Science 1998; 282:2012-8.
8. Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. The Arabidopsis genome initiative. Nature 2000;408:796-815.
9. P. Kaiser, B. Auer, and M. Schweiger Inhibition of cell proliferation in Saccharomyces cerevisiae by expression of human NAD+ ADP-ribosyltransferase requires the DNA binding domain ("zinc fingers") Mol Gen Genet 232 1992 231 239
10. E. Perkins, D. Sun, A. Nguyen, S. Tulac, M. Francesco, and H. Tavana Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast Cancer Res 61 2001 4175 4183
11. J. Zhang, and J. Li PARP and PARG as novel therapeutic targets Drugs Future 27 2002 371 383
12. K. Aoki, K. Nishimura, H. Abe, H. Maruta, H. Sakagami, and T. Hatano Novel inhibitors of poly(ADP-ribose) glycohydrolase Biochim Biophys Acta 1158 1993 251 256
13. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliv Rev 46 2001 3 26
14. M. Tavassoli, M.H. Tavassoli, and S. Shall Effect of DNA intercalators on poly(ADP-ribose) glycohydrolase activity Biochim Biophys Acta 827 1985 228 234
15. J. Li, and J. Zhang Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors for inhibiting or decreasing free radical-induced cellular energy depletion, cell damage or cell death WO 2000 00025787
16. W. Ying, M.B. Sevigny, Y. Chen, and R.A. Swanson Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death Proc Natl Acad Sci USA 98 2001 12227 12232
17. W. Ying, and R.A. Swanson The poly(ADP-ribose) glycohydrolase inhibitor gallotannin blocks oxidative astrocyte death NeuroReport 11 2000 1385 1388
18. Li J, Ferraris DV, Kletzly PW, Li W, Wang E, Xing A et al. Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly(ADP-ribose) glycohydrolase, and methods for their use. WO, 2002, 02057211.
19. S. Hanay, M. Kanay, S. Ohashi, K. Okamoto, M. Yamada, and H. Tahagashi Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster Proc Nad Acad Sci USA 101 2004 82 86
20. D.W. Koh, Lawler Am, M.F. Poitras, M. Sasaki, S. Wattler, and Nehls Mc Failure to degrade poly(ADP-ribose) causes increased sensitivity to citotoxiticy and early embryonic lethality Proc Nad Acad Sci USA 101 2004 17699 17704
21. U. Cortes, W.M. Tong, D.L. Coyle, M.L. Meyer-Ficca, R.G. Meyer, and V. Petrilli Depletion of the 110-kilodalton isoform op poly(ADP-ribose) glycohydrosilase increases sensitivity to genotoxic and endotoxic stress in mice Mol Cell Biol 16 2004 7163 7178
22. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
23. E.A. Faist, E. Baue, and Dittmer Multiple organ failure in poly-trauma patients J Trauma 23 1983 775 787
24. W.G. Marshall, and A.R. Dimick Natural history of major burns with multiple subsystem failure J Trauma 23 1983 102 105
25. J.R. Saffle, J.J. Sullivan, and G.M. Tuohig Multiple organ failure in patients with thermal injury Crit Care Med 21 1993 1673 1683
26. N. Aikowa, Y. Shinozawa, and K. Ishibiki Clinical analysis of multiple organ failure in burned patients Burns 13 1987 103 109
27. D.B. Allardyce Incidence of necrotising pancreatitis and factors related to mortality Am J Surg 154 1987 295 299
28. A.E. Baue, and D. Guthrie Multiple system failure and circulatory support Jpn J Surg 13 1983 69 85
29. J.R. Shayevitz, C. Miller, K.J. Johnson, and J.L. Rodriguez Multiple organ dysfunction syndrome: end organ and systemic inflammatory response in a mouse model of nonseptic origin Shock 4 1995 389 396
30. Goris RJA, I.P. van Bebber, R.M. Mollen, and J.P. Koopman Dose selective decontamination of the gastrointestinal tract prevent multiple organ failure? Arch Surg 126 1991 561 565
31. R. Demling, U. Nayak, K. Ikegami, and C. LaLonde Comparison between lung and liver peroxidation and mortality after zymosan peritonitis in the rats Shock 2 1994 222 227
32. I.P. van Bebber, W.K. Boekholz, R.J. Goris, P.H. Schillings, H.P. Dinges, and S. Bahrami Neutrophil function and lipid peroxidation in rat model of multiple organ failure J Surg Res 47 1989 471 475
33. Von Asmuth EJU, I.G. Maessen, C.J. van der Linden, and W.A. Buurman Tumor necrosis factor alpha (TNFα) and interleukin 6 in zymosan-induced shock model Scand J Immunol 32 1990 313 319
34. F. Petit, G.J. Bagby, and C.H. lang Tumor necrosis factor mediates zymosan induced increase in glucose flux and insulin resistance Am J Physiol 268 1995 219 228
35. J. Damas, G. Remacle-Volon, and V. Bourdon Platelet-activating factor and vascular effects of zymosan in rats Eur J Pharmacol 231 1993 231 236
36. E.A. Deitch, L. Ma, R.D. Berg, R.D. Berg, and R.D. Specian Protein malnutrition predisposes to inflammatory-induced gut-origin septic states Ann Surg 221 1990 560 568
37. M.R. Mainous, W. Ertel, I.H. Chaudry, and E.A. Deitch The gut: a cytokine-generating organ in systemic inflammation? Shock 4 1995 193 199
38. L.L. Thomsen, L.M. Ching, and B.C. Baguley Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic and xanthenone-4-acetic acid Cancer Res 50 1990 6966 6970
39. B. Zingarelli, F. Squadrito, D. Altavilla, G. Calapai, G.M. Campo, and M. Calo Evidence for role of nitric oxide in hypovolemic hemorrhagic shock J Cardiovasc Pharmacol 19 1992 982 986
40. J.L. Parker, and H.R. Adams Selective inhibition of endothelium-dependent vasodilatator capacity by Escherichia coli endotoxaemia Circ Res 72 1993 539 551
41. J.S. Beckman, T.W. Beckman, J. Chen, P.A. Marshall, and B.A. Freeman Apparent hydroxyl radical production by PN: implication for endothelial injury from nitric oxide and superoxide Proc Natl Acad Sci USA 87 1990 1620 1624
42. S. Cuzzocrea, G. De Sarro, G. Costantino, E. Mazzon, R. Laura, and E. Ciriaco Role of interleukin-6 in a non-septic shock model induced by zymosan Eur Cytokine Network 10 1999 191 203
43. P.A. Ward, G.O. Till, R. Kunkel, and C. Beauchamp Evidence for role of hydroxyl radical complement and neutrophil-dependent tissue injury J Clin Invest 72 1983 789 801
44. J.C. Fantone, and P.A. Ward A review: role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions Am J Pathol 107 1982 395 418
45. T. Genovese, R. Di Paola, P. Catalano, J.H. Li, W. Xu, and E. Massuda Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice Crit Care Med 32 2004 1365 1374
46. Centers for Disease Control and Prevention, National Center for Health Statistics. Mortality patterns - United States, 1990. Monthly Vital Stat Report 1993;41:45.
47. American College of Chest Physicians - Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-75.
48. I. De Warra, C. Jaccard, S.B. Corradin, R. Chiolero, B. Yersin, and H. Gallati Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock and bacterial pneumonia Crit Care Med 25 1997 607 613
49. J.H. Siegel, M. Greenspan, and LR.M. Del Guercio Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock Ann Surg 165 1967 504 551
50. H. Macarthur, D.M. Couri, G.H. Wilken, T.C. Westfall, A.J. Lechner, and G.M. Matuschak Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines Crit Care Med 31 2003 237 245
51. Groeneveld ABJ, W. Bronsveld, and L.G. Thijs Hemodynamic determinants of mortality in human septic shock Surgery 99 1986 140 152
52. B. Levy, P.E. Bollaert, C. Charpentier, L. Nace, G. Audibert, and P. Bauer Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study Intensive Care Med 23 1997 282 287
53. C. Martin, X. Viviand, M. Leone, and X. Thirion Effect of norepinephrine on the outcome of septic shock Crit Care Med 28 2000 2758 2765
54. C. Thiemermann The role of the l-arginine: nitric oxide pathway in circulatory shock Adv Pharmacol 28 1994 45 79
55. D.E. Taylor, A.J. Ghio, and C.A. Piantadosi Reactive oxygen species produced by liver mitochondria of rats in sepsis Arch Biochem Biophys 316 1995 70 76
56. M. Tewari, L.T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, and D.R. Beidler Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase Cell 81 1995 801 809
57. H. Macarthur, T.C. Westfall, D.P. Riley, T.P. Misko, and D. Salvemini Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock Proc Natl Acad Sci USA 97 2000 9753 9758
58. F.J. Oliver, J. Menissier-de Murcia, C. Nacci, P. Decker, R. Andriantsitohaina, and S. Muller Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly(ADP-ribose)polymerase-1 deficient mice EMBO J 18 1999 4446 4454
59. P.O. Hassa, and M.O. Hottiger A role of poly(ADP-ribose)polymerase in NF-kappaB transcriptional activation Biol Chem 380 1999 953 959
60. P.O. Hassa, M. Covic, S. Hasan, R. Imhof, and M.O. Hottiger The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappaB coactivator function J Biol Chem 276 2001 45588 45597
61. Z. Herceg, V. Pétrilli, A. Wutz, B. Auer, M-P. Cros, and Z-Q. Wang Functional testing of human PARP in proliferation, endotoxic shock and radiosensitivity: A genetic rescue study J. Zhang PARP as a therapeutic target 2001 67 81
62. U. Cortes, W.M. Tong, D.L. Coyle, M.L. Meyer-Ficca, R.G. Meyer, and V. Petrilli Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice Mol Cell Biol 24 2004 7163 7178
63. A.M. Lefer Physiologic and pathophysiologic role of cyclo-oxygenase metabolites of arachidonic acid in circulatory disease states Cardiovasc Clin 18 1987 85 99
64. A.M. Lefer, and D.J. Lefer Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock Annu Rev Pharmacol Toxicol 33 1993 71 90
65. Zimmermann BJ, Arndt H, Kubes P, Kurtel H. In: Schlag G, Redl H, editors. Reperfusion injury in the small intestine. Berlin: Springer-Verlag; 1993. p. 322.
66. H. Bitterman, and A.M. Lefer Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock Prostaglandins Leukot Essent Fatty Acids 32 1988 63 70
67. H. Bitterman, P. Reissman, N. Bitterman, Y. Melamed, and L. Cohen Oxygen therapy in hemorrhagic shock Circ Shock 33 1991 183 191
68. B. Zingarelli, F. Squadrito, M. Inoculano, D. Altavilla, F. Bussolino, and G.M. Campo Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock Eur J Pharmacol 222 1992 13 19
69. S. De Bono SOD mimic minimizes pain Trends Biochem Sci 26 2001 283
70. S. Cuzzocrea, D.P. Riley, A.P. Caputi, and D. Salvemini Antioxidant therapy: a new pharmacological approach in shock, inflammation, andischemia/reperfusion injury Pharmacol Rev 53 2001 135 159
71. R.E. Ratych, R.S. Chuknyska, and G.B. Burkley The primary localisation of free radical generation after anoxia/reoxygenation in isolated endothelial cells Surgery 102 1987 122 131
72. D.N. Granger, G. Rutili, and J.M. McCord Superoxide radicals in feline intestinal ischemia Gastroenterology 81 1981 22 23
73. G. Folkerts, J. Kloek, R.B. Muijsers, and F.P. Nijkamp Reactive nitrogen and oxygen species in airway inflammation Eur J Pharmacol 429 2001 251 262
74. L.M. Walker, J.L. York, S.Z. Imam, S.F. Ali, K.L. Muldrew, and P.R. Mayeux Oxidative stress and reactive nitrogen species generation during renal ischemia Toxicol Sci 63 2001 143 148
75. J.M. Harlan Leukocyte-endothelial interactions Blood 65 1985 513 525
76. D.E. Lorant, K.D. Patel, T.M. McIntyre, R.P. McEver, S.M. Prescott, and G.A. Zimmerman Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils J Cell Biol 115 1991 223 234
77. K.D. Patel, G.A. Zimmerman, S.M. Prescott, R.P. McEver, and T.M. McIntyre Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils J Cell Biol 112 1991 749 759
78. D.E. Lorant, M.K. Topham, R.E. Whatley, R.P. McEver, T.M. McIntyre, and S.M. Prescott Inflammatory roles of P-selectin J Clin Invest 92 1993 559 570
79. E.C. Butcher Specificity of leukocyte-endothelial interactions and diapedesis: physiologic and therapeutic implications of an active decision process Res Immunol 144 1993 695 698
80. S.J. Wetheimer, C.L. Myers, R.W. Wallace, and T.P. Parks Intercellular adhesion molecule-1 gene expression in human endothelial cells J Biol Chem 267 1992 12030 12035
81. M.S. Cappell Intestinal (mesenteric) vasculopathy. II. Ischemic colitis and chronic mesenteric ischemia Gastroenterol Clin North Am 27 1998 827 860
82. S. Homer-Vanniasinkam, J.N. Crinnion, and M.J. Gough Post-ischaemic organ dysfunction: a review Eur J Vasc Endovasc Surg 14 1997 195 203
83. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
84. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
85. C.G. Su, X. Wen, S.T. Bailey, W. Jiang, S.M. Rangwala, and S.A. Keilbaugh A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response J Clin Invest 104 1999 383 389
86. Cuzzocrea S, Di Paola R, Mazzon E, Cortes U, Genovese T, Muià C, et al. PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion. FASEB J, in press.
87. P.T. Akins, P.K. Liu, and C.Y. Hsu Immediate early gene expression in response to cerebral ischemia. Friend or foe? Stroke 27 1996 1682 1687
88. F.C. Barone, and G.Z. Feuerstein Inflammatory mediators and stroke: new opportunities for novel therapeutics J Cereb Blood Flow Metab 19 1999 819 834
89. T. Higashi, H. Takechi, Y. Uemura, H. Kikuchi, and K. Nagata Differential induction of mRNA species encoding several classes of stress proteins following focal cerebral ischemia in rats Brain Res 650 1994 239 248
90. F. Gillardon, C. Lenz, K.F. Waschke, S. Krajewski, J.C. Reed, and M. Zimmermann Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats Brain Res Mol Brain Res 40 1996 254 260
91. E.P. Dixon, D.T. Stephenson, J.A. Clemens, and S.P. Little Bcl-Xshort is elevated following severe global ischemia in rat brains Brain Res 776 1997 222 229
92. F. Cimino, F. Esposito, R. Ammendola, and T. Russo Gene regulation by reactive oxygen species Curr Top Cell Regul 35 1997 123 148
93. D.A. Greenberg Gene-based therapy for stroke: preclinical perspectives Drug New perspect 9 1996 517 523
94. S. Lautar, A.A. Pieper, A. Verma, Lu XCM, Z. Tang, and W. Liu Post ischemia treatment with GPI 6150 diminishes poly(ADP-ribose) accumulation during ischemia-reperfusion injury in rat brain Soc Neurosci Abstr 24 1998 1226
95. L. Virag, and C. Szabo The therapeutic potential of poly(ADP-ribose) polymerase inhibitors Pharmacol Rev 54 2002 375 429
96. M.J. Eliasson, K. Sampei, A.S. Mandir, P.D. Hurn, R.J. Traystman, and J. Bao Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia Nat Med 3 1997 1089 1095
97. X.C. Lu, E. Massuda, Q. Lin, W. Li, J.H. Li, and J. Zhang Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat Brain Res 978 2003 99 103
98. A.M. Sheridan, and J.V. Bonventre Pathophysiology of ischemic acute renal failure Contrib Nephrol 132 2001 7 21
99. M.S. Paller The cell biology of reperfusion injury in the kidney J Invest Med 42 1994 632 639
100. A. Kribben, C.L. Edelstein, and R.W. Schrier Pathophysiology of acute renal failure J Nephrol 2 1999 S142 S151
101. M.S. Paller Pathophysiologic mechanisms of acute renal failure R.S. Goldstein Mechanisms of injury in renal disease and toxicity 1994 CRC Ann Arbor, USA 3
102. P.K. Chatterjee, B.E. Chatterjee, H. Pedersen, A. Sivarajah, M.C. McDonald, and H. Mota-Filipe 5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion Kidney Int 65 2004 499 509
103. N.S. Patel, U. Cortes, R. Di Paola, E. Mazzon, H. Mota-Filipe, and S. Cuzzocrea Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury J Am Soc Nephrol 16 2005 712 719